Rise Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-340
Closed -$8.42K 109
2025
Q3
$8.42K Hold
340
﹤0.01% 1070
2025
Q2
$7.71K Hold
340
﹤0.01% 1112
2025
Q1
$10.3K Buy
340
+80
+31% +$3.05K ﹤0.01% 946
2024
Q4
$10.3K Hold
260
0.01% 978
2024
Q3
$16.5K Hold
260
0.01% 817
2024
Q2
$17.6K Hold
260
0.01% 713
2024
Q1
$20.6K Buy
+260
New +$21.3K 0.01% 632

Other funds holding ACHC

Rise Advisors's ACHC Position: Q4 2025 in Review

Rise Advisors sold out of Acadia Healthcare (ACHC) in Q4 2025, closing a stake of 340 shares — an estimated $8.42K sold.

Rise Advisors first reported a position in ACHC in Q1 2024 and held it in 7 quarters. The position peaked at $20.6K in Q1 2024. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.

  • Rise Advisors reported no remaining Acadia Healthcare position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 340 Acadia Healthcare shares in Q4 2025, an estimated $8.42K.
  • Rise Advisors first reported a position in Acadia Healthcare in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Acadia Healthcare position peaked at $20.6K in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.